TCIRG1

Chr 11AR

T cell immune regulator 1, ATPase H+ transporting V0 subunit a3

Also known as: ATP6N1C, ATP6V0A3, Atp6i, OC-116kDa, OC116, OPTB1, Stv1, TIRC7

This protein is a subunit of the vacuolar H+-ATPase complex that pumps protons across membranes to regulate cellular and extracellular pH, which is essential for processes like protein sorting and receptor-mediated endocytosis. Mutations cause autosomal recessive infantile malignant osteopetrosis, a severe bone disease with early onset that affects bone resorption and can involve immune dysfunction. The gene shows very low constraint against loss-of-function variants in the general population.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.871 OMIM phenotype
Clinical SummaryTCIRG1
🧬
Gene-Disease Validity (ClinGen)
autosomal recessive osteopetrosis 1 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
77 unique Pathogenic / Likely Pathogenic· 277 VUS of 600 total submissions
📖
GeneReview available — TCIRG1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.87LOEUF
pLI 0.000
Z-score 2.26
OE 0.63 (0.460.87)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.63Z-score
OE missense 0.92 (0.860.99)
489 obs / 529.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.63 (0.460.87)
00.351.4
Missense OE0.92 (0.860.99)
00.61.4
Synonymous OE1.04
01.21.6
LoF obs/exp: 27 / 43.0Missense obs/exp: 489 / 529.6Syn Z: -0.47
DN
0.78top 25%
GOF
0.81top 10%
LOF
0.1895th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

600 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic47
VUS277
Likely Benign230
Benign2
Conflicting2
30
Pathogenic
47
Likely Pathogenic
277
VUS
230
Likely Benign
2
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
29
0
1
0
30
Likely Pathogenic
42
3
2
0
47
VUS
4
235
25
13
277
Likely Benign
0
1
125
104
230
Benign
0
0
2
0
2
Conflicting
2
Total75239155117588

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TCIRG1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →